MindBio Therapeutics Corp is a publicly traded innovation company focused on developing and commercializing AI-powered health prediction technologies using human voice biomarkers. The company pioneers acoustic biomarker technology that transforms human voice into actionable health intelligence, enabling real-time intoxication detection and sobriety verification. It engages in researching, developing, and testing psychedelic substances as potential treatments, alongside building prediction technologies through rigorous research and clinical trials to optimize human health outcomes. MindBio Therapeutics Corp also advances telehealth insights, offering revolutionary AI platforms for early health detection in sectors like mental health and substance monitoring. Founded in 2014 and headquartered in Vancouver, Canada, it plays a key role in the intersection of biotechnology, artificial intelligence, and precision medicine.